Pancreatic cancer pill raises huge hopes after trial saw tumours vanish
Author: Michelle RobertsPublished on: November 20, 2026Country: United Kingdom
HealthScience

In an early trial involving 61 people with advanced pancreatic cancer, daraxonrasib combined with chemotherapy stopped tumours growing in 90% of patients. Tumours shrank or disappeared in just over 60%, and became undetectable on CT scans in about one in 12. Cancer Research UK called the findings the biggest leap forward in decades, but doctors stressed the treatment is not a cure and longer studies are needed to establish how long it can control the disease.
Read original article
bbc.co.ukStay informed with NewsBoulevard
Get the latest news summaries delivered to your inbox


